Partner David Rosen was quoted in a Washington Post article, “Regulators Take a Growing Interest in Drugmakers’ Moves to Protect Profits,” on March 19, 2015. The article discussed the competitive nature of patents for the prescription drug market, along with related antitrust issues. Rosen was quoted saying, “This industry is under a lot of scrutiny because the cost savings in the generic world are pretty high for the public.”
23 February 2024 In the News
Christopher Swift Comments on New U.S. Sanctions Against Russia
Foley & Lardner LLP partner Christopher Swift is quoted in the CBS article, “U.S. issues hundreds of new Russia sanctions over Alexey Navalny's death and war in Ukraine.”
22 February 2024 In the News
Louis Lehot Authors Article on the Business of Space Tourism
Foley & Lardner LLP partner Louis Lehot authored The Recorder article, “An M&A Lawyer's Insight Into Earth's Challenges From Outer Space,” exploring the growing business of space tourism and the plans underway for expanding this novel form of escape.
21 February 2024 In the News
Kate Gehl and Paul Piaskoski Author Article on FTC Approach to AI
Foley & Lardner LLP partner Kate Gehl and associate Paul Piaskoski authored the IP Litigator article, “FTC Weighs in on Threats to Competition from Artificial Intelligence in Comment to U.S. Copyright Office,” exploring the U.S. Federal Trade Commission’s approach to the emerging technology.